Biosimilars: Impact on Cost

Show Description +

Peter Kaiser, MD, shows evidence on impact of biosimilars on cost of treatment in oncology and rheumatology.

Posted: 4/14/2023

Keywords:

biosimilars

Oncology

rheumatology

Biogen

Biosimilars: Impact on Cost

Peter Kaiser, MD, shows evidence on impact of biosimilars on cost of treatment in oncology and rheumatology.

Posted: 4/14/2023

Keywords:

biosimilars

Oncology

rheumatology

Biogen

Resources

Biosimilars in Retinal Disease Management

View Resource

About Biogen

One of the world’s first global biotechnology companies, Biogen, was founded in 1978 by Charles Weissmann, Heinz Schaller, Sir Kenneth Murray, and Nobel Prize winners Walter Gilbert and Phillip Sharp. Biogen is commercializing biosimilars and transforming the standard of care for patients in several areas of high unmet need.